SE7803195L - Forfarande for framstellning av 1,2,4-triazinderivat med farmakologisk verkan - Google Patents
Forfarande for framstellning av 1,2,4-triazinderivat med farmakologisk verkanInfo
- Publication number
- SE7803195L SE7803195L SE7803195A SE7803195A SE7803195L SE 7803195 L SE7803195 L SE 7803195L SE 7803195 A SE7803195 A SE 7803195A SE 7803195 A SE7803195 A SE 7803195A SE 7803195 L SE7803195 L SE 7803195L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- pharmacological effect
- triazine derivatives
- triazine
- Prior art date
Links
- 150000003920 1,2,4-triazines Chemical class 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12598/77A GB1584461A (en) | 1977-03-25 | 1977-03-25 | Imidazotriazines imidazotriazinones and pharmaceutical compositions containing them |
| GB4725077 | 1977-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7803195L true SE7803195L (sv) | 1978-09-26 |
Family
ID=26249130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7803195A SE7803195L (sv) | 1977-03-25 | 1978-03-20 | Forfarande for framstellning av 1,2,4-triazinderivat med farmakologisk verkan |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4278673A (sv) |
| JP (1) | JPS53119891A (sv) |
| AT (1) | AT363952B (sv) |
| AU (1) | AU516179B2 (sv) |
| DE (1) | DE2811780A1 (sv) |
| DK (1) | DK109578A (sv) |
| ES (1) | ES468119A1 (sv) |
| FI (1) | FI780828A (sv) |
| FR (1) | FR2384773A1 (sv) |
| IE (1) | IE46653B1 (sv) |
| IT (1) | IT1105177B (sv) |
| NL (1) | NL7803195A (sv) |
| NZ (1) | NZ186699A (sv) |
| SE (1) | SE7803195L (sv) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496927A (en) * | 1985-02-04 | 1996-03-05 | Merrell Pharmaceuticals Inc. | Peptidase inhibitors |
| US4687776A (en) * | 1986-10-24 | 1987-08-18 | Warner-Lambert Company | Drug stabilization |
| US4788064A (en) * | 1987-07-31 | 1988-11-29 | Warner-Lambert Company | Transdermal delivery system |
| US5208226A (en) * | 1989-09-08 | 1993-05-04 | Glaxo Group Limited | Medicaments |
| US5270305A (en) * | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
| HU230154B1 (hu) * | 1997-11-12 | 2015-09-28 | Bayer Intellectual Property Gmbh | Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására |
| DE19827640A1 (de) | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
| DE10063106A1 (de) * | 2000-12-18 | 2002-06-20 | Bayer Ag | Verfahren zur Herstellung von 2-(2-Ethoxyphenyl)-substituierten Imidazotriazinonen |
| DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
| JP4540295B2 (ja) * | 2001-05-09 | 2010-09-08 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | ２−フェニル置換イミダゾトリアジノンの新しい用途 |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| US7087605B2 (en) * | 2001-06-01 | 2006-08-08 | Bayer Aktiengesellschaft | 5-Ethyl-imidazotriazinones |
| GB0113344D0 (en) | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| DE10130167A1 (de) | 2001-06-22 | 2003-01-02 | Bayer Ag | Imidazotriazine |
| DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| GB0209988D0 (en) * | 2002-05-01 | 2002-06-12 | Bayer Ag | Novel Heterocycles |
| GB2388111A (en) * | 2002-05-01 | 2003-11-05 | Bayer Ag | Novel imidazotriazinone compounds |
| GB2388594A (en) * | 2002-05-16 | 2003-11-19 | Bayer Ag | Imidazo-triazine PDE 4 inhibitors |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| WO2004087652A2 (en) * | 2003-04-01 | 2004-10-14 | Smithkline Beecham Corporation | Imidazotriazine compounds |
| JP2008501617A (ja) * | 2004-06-11 | 2008-01-24 | アスビオファーマ株式会社 | Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体 |
| JP2008516071A (ja) * | 2004-10-13 | 2008-05-15 | クナーフ インシュレーション ゲーエムベーハー | ポリエステル結合性組成物 |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| SG166106A1 (en) * | 2005-09-29 | 2010-11-29 | Bayer Schering Pharma Ag | Pde inhibitors and combinations thereof for the treatment of urological disorders |
| DE102006048693A1 (de) * | 2006-10-14 | 2008-04-17 | Bayer Healthcare Ag | Inhibition der PDE2A |
| WO2008151734A1 (en) * | 2007-06-13 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
| GB1457873A (en) * | 1973-01-04 | 1976-12-08 | Allen & Hanburys Ltd | Imidazotriazines |
-
1978
- 1978-03-10 DK DK109578A patent/DK109578A/da unknown
- 1978-03-14 NZ NZ186699A patent/NZ186699A/xx unknown
- 1978-03-16 FI FI780828A patent/FI780828A/fi not_active Application Discontinuation
- 1978-03-17 DE DE19782811780 patent/DE2811780A1/de not_active Withdrawn
- 1978-03-20 SE SE7803195A patent/SE7803195L/sv unknown
- 1978-03-20 AU AU34314/78A patent/AU516179B2/en not_active Expired
- 1978-03-20 AT AT0196378A patent/AT363952B/de not_active IP Right Cessation
- 1978-03-21 ES ES468119A patent/ES468119A1/es not_active Expired
- 1978-03-22 FR FR7808309A patent/FR2384773A1/fr active Granted
- 1978-03-22 IT IT48546/78A patent/IT1105177B/it active
- 1978-03-23 NL NL7803195A patent/NL7803195A/xx not_active Application Discontinuation
- 1978-03-25 JP JP3479778A patent/JPS53119891A/ja active Pending
- 1978-03-29 IE IE625/78A patent/IE46653B1/en unknown
-
1979
- 1979-09-04 US US06/072,098 patent/US4278673A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE780625L (en) | 1978-09-25 |
| FR2384773B1 (sv) | 1980-07-04 |
| AU516179B2 (en) | 1981-05-21 |
| FI780828A (fi) | 1978-09-26 |
| NZ186699A (en) | 1980-12-19 |
| AU3431478A (en) | 1979-09-27 |
| NL7803195A (nl) | 1978-09-27 |
| IE46653B1 (en) | 1983-08-10 |
| IT1105177B (it) | 1985-10-28 |
| US4278673A (en) | 1981-07-14 |
| FR2384773A1 (fr) | 1978-10-20 |
| ATA196378A (de) | 1981-02-15 |
| JPS53119891A (en) | 1978-10-19 |
| DE2811780A1 (de) | 1978-09-28 |
| ES468119A1 (es) | 1979-09-01 |
| IT7848546A0 (it) | 1978-03-22 |
| DK109578A (da) | 1978-09-26 |
| AT363952B (de) | 1981-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7803195L (sv) | Forfarande for framstellning av 1,2,4-triazinderivat med farmakologisk verkan | |
| SE7805590L (sv) | Forfarande for framstellning av aminoalkylderivat med farmaceutisk verkan | |
| SE7805591L (sv) | Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan | |
| AR224095A1 (es) | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 | |
| NO821847L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
| SE429338B (sv) | Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan | |
| SE7701379L (sv) | Forfarande for framstellning av bensendimetanolderivat med farmakologisk verkan | |
| SE7803035L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| AR218498A1 (es) | Procedimiento de preparacion de derivados de 1,3-difenoxipropan-2-ona | |
| NO784382L (no) | Fremgangsmaate for fremstilling av tiazoldin-derivater | |
| AR211570A1 (es) | Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo | |
| SE440907B (sv) | Forfarande for framstellning av imidazolderivat med farmaceutisk verkan | |
| SE434263B (sv) | Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan | |
| SE7804736L (sv) | Forfarande for framstellning av isoindolinderivat med terapeutisk verkan | |
| SE7804878L (sv) | Forfarande for framstellning av 1,2-dikloretan | |
| AR224501A1 (es) | Procedimiento de preparacion de derivados de la tieno-(3,2-c)-piridina | |
| SE7800930L (sv) | Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan | |
| SE7703721L (sv) | Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan | |
| FI782517A (fi) | Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner | |
| NO780389L (no) | Fremgangsmaate for fremstilling av erytromycin-derivater | |
| FI780694A (fi) | Foerfarande foer framstaellning av 2,1,3-tiadiazin-4-on-2,2-dioxidderivat | |
| SE7709402L (sv) | Forfarande for framstellning av tetrahydropyridinderivat | |
| SE7805105L (sv) | Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat |